Low prevalence of hepatitis E in Iceland: a seroepidemiological study

Scandinavian Journal of Gastroenterology

Volumn 53, Issue 3, 2018, Pages 293-296

  Löve, Arthur ^a,b   Björnsdottir, Thora B ^b   Olafsson, Sigurdur ^b   Björnsson, Einar S ^a,b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Hepatitis E; Iceland; seroepidemiology

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; AGRICULTURAL WORKER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS E; HUMAN; ICELAND; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROEPIDEMIOLOGY; SEROPREVALENCE; TOXIC HEPATITIS; ANIMAL; ANIMAL HOUSING; BLOOD; CASE CONTROL STUDY; HEPATITIS E VIRUS; MIDDLE AGED; PIG;

ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FARMERS; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HEPATITIS E VIRUS; HOUSING, ANIMAL; HUMANS; ICELAND; IMMUNOBLOTTING; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SWINE;

EID: 85043460094     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365521.2017.1420218     Document Type: Article

References (31)

1. Aggarwal R, Jameel S., Hepatitis E. Hepatology. 2011;54:2218–2226.
2. Hoofnagle JH, Nelson KE, Purcell RH., Hepatitis E. N Engl J Med. 2012;367:1237–1244.
3. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358:811–817.
4. Meng XJ, Wiseman B, Elvinger F, et al. Prevalence of antibodies to hepatitis E virus in veterinarians working with swine and in normal blood donors in the United States and other countries. J Clin Microbiol. 2002;40(1):117–122.
5. Kuniholm MH, Purcell RH, McQuillan GM, et al. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition ExaminationSurvey, 1988–1994. J Infect Dis. 2009;200:48–56.
6. Olsen B, Axelsson-Olsson D, Thelin A, et al. Unexpected high prevalence of IgG-antibodies to hepatitis E virus in Swedish pig farmers and controls. Scand J Infect Dis. 2006;38:55–58.
7. Christensen PB, Engle RE, Jacobsen SE, et al. High prevalence of hepatitis E antibodies among Danish prisoners and drug users. J Med Virol. 2002;66:49–55.
8. Davern TJ, Chalasani N, Fontana RJ, et al. Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology. 2011;141:1665–1672.
9. Norder H, Karlsson M, Mellgren Å, et al. Diagnostic performance of five assays for Anti-Hepatitis E Virus IgG and IgM in a large cohort study. J Clin Microbiol. 2016;54(3):549–555.
10. Helgadottir H, Metz DC, Yu-Xiao Y, et al. The effects of long-term therapy with proton pump inhibitors on meal stimulated gastrin. Dig Liver Dis. 2014;46:125–130.
11. Bjornsson ES, Bergmann OM, Bjornsson HK, et al. Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology. 2013;144:1419–1425.
12. Hartl J, Otto B, Madden R, et al. Hepatitis E seroprevalence in Europe: a meta-analysis. Viruses. 2016;8(8):211. DOI:10.3390/v8080211
13. Bendall R, Ellis V, Ijaz S, et al. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol. 2010;82:799–805.
14. Poovorawan Y, Theamboonlers A, Chumdermpadetsuk S, et al. Prevalence of hepatitis E virus infection in Thailand. Ann Trop Med Parasitol. 1996;90:189–196.
15. The global prevalence of hepatitis E virus infection and susceptibility: a systematic review [Internet]. World Health Organization; 2010. Available from: whqlibdoc.who.int/hq/2010/WHO_IVB_10.14_eng.pdf
16. Verhoef L, Koopmans M, Duizer E, et al. Seroprevalence of hepatitis E antibodies and risk profile of HEV seropositivity in The Netherlands, 2006–2007. Epidemiol Infect. 2012;140:1838–1847.
17. Herremans M, Bakker J, Duizer E, et al. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol. 2007;14(5):562–568.
18. Chen EY, Baum K, Collins W, et al. Hepatitis E masquerading as drug-induced liver injury. Hepatology. 2012;56:2420–2423.
19. Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med. 2009;361:1025–1027.
20. Tamura A, Shimizu YK, Tanaka T, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res. 2007;37:113–120.
21. Meng XJ. From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res. 2011;161:23–30.
22. Takahashi K, Kitajima N, Abe N, et al. Complete or near-complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology. 2004;330:501–505.
23. Roth A, Lin J, Magnius L, et al. Markers for ongoing or previous Hepatitis E virus infection are as common in wild ungulates as in humans in Sweden. Viruses. 2016;8(9):259–271.
24. Lin J, Karlsson M, Olofson AS, et al. High prevalence of hepatitis E virus in Swedish moose–a phylogenetic characterization and comparison of the virus from different regions. PLoS One. 2015;10(4):e0122102.
25. Lin J, Norder H, Uhlhorn H, et al. Novel hepatitis E like virus found in Swedish moose. J Gen Virol. 2014;95(3):557–570.
26. Widén F, Sundqvist L, Matyi-Toth A, et al. Molecular epidemiology of hepatitis E virus in humans, pigs and wild boars in Sweden. Epidemiol Infect. 2011;139(3):361–371.
27. Xia H, Liu L, Linde AM, et al. Molecular characterization and phylogenetic analysis of the complete genome of a hepatitis E virus from European swine. Virus Genes. 2008;37(1):39–48.
28. Norder H, Sundqvist L, Magnusson L, et al. Endemic hepatitis E in two Nordic countries. Eurosurveillance. 2009;14(19):20–28.
29. European Association for the Study of the Liver. EASL clinical practice guidelines: autoimmune hepatitis. J Hepatol. 2015;63:971–1004.
30. Kamar K, Dalton HR, Abravanel F, et al. Hepatitis E virus infection. Clin Microbiol Rev. 2014;27(1):116–138.
31. Blasco-Perrin H, Abravanel F, Blasco-Baque V, et al. Hepatitis E, the neglected one. Liver Int. 2016;36:130–134.